Table 2.
Clinical Characteristics of 17 Patients Meeting 2009 NCCN Diagnostic Criteria for Cowden Syndrome
|
Major CS criteriaa |
Minor CS criteria |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
Gender/race | PTEN result | Thyroid cancer histology | Macrocephaly (HC in cm) | Benign thyroid | GI hamartomas | FCBD | Lipomas | Fibromas | GU tumors/defects | Uterine fibroids |
F/African American | R15Sb | FTC | Y (58.5) | N | Y | N | N | N | N | N |
F/Caucasian | R130Qb | FTC | Y (62) | Y | U | N | N | N | N | N |
M/Caucasian | Negativeb | PTC | Y (60.25) | N | N | N | N | N | N | N |
F/Caucasian | Negativeb | PTC | Y (60.25) | Y | U | N | N | N | N | U |
M/Caucasian | Negativeb | PTC, FV | Y (60) | N | N | N | Y | N | N | NA |
F/African America | Negativeb | PTC, FV | N (56.5) | N | N | Y | N | N | Y | Y |
F/Caucasian | Negativeb | PTC, FV | N (55.5) | Y | N | Y | Y | N | N | Y (nc) |
F/Caucasian | Negativeb | PTC, FV | N (54.5) | N | N | Y | Y | N | N | Y |
M/Caucasian | Negativec | microPTC | Y (63.5) | Y | N | N | N | N | N | NA |
M/Caucasian | Negativec | FTC, OV | Y (61) | Y | N | N | N | N | N | NA |
M/Caucasian | Negativec | PTC | Y (60) | N | N | N | Y | N | N | NA |
M/Caucasian | Negativec | PTC, tall cell | Y (60) | N | N | N | N | N | N | N |
F/Caucasian | Negativec | microPTC | Y (59) | N | N | N | N | N | N | N |
F/Caucasian | Negativec | FTC, OV | N (56.5) | Y | N | Y | N | N | N | Y |
F/Caucasiand | Negativec | PTC | N (56) | N | Y | Y | N | N | N | Y (nc) |
F/Caucasian | Negativec | FTC | N (55.5) | N | Y | Y | N | Y | N | N |
F/Caucasian | Negativec | PTC, FV | N (55.5) | Y | N | Y (nc) | N | N | N | Y |
No patient met pathognomonic CS criteria or had breast or endometrial cancer.
Genetic testing by denaturing gradient gel electrophoresis.
Genetic testing by LightScanner.
Patient had single trichilemmoma confirmed by pathology as well as multiple keratoses.
HC, head circumference; GI, gastrointestinal; FCBD, fibrocystic breast disease; GU, genitourinary; PTC, papillary thyroid carcinoma; FTC, follicular thyroid carcinoma; OV, oncocytic variant; fv, follicular variant; Y, yes; N, no; U, unknown M, male; F, female; NA, not applicable; nc, per patient report only, not confirmed with medical records.